In the ER+HER2– BC group, the CPBS score was calculated by summing the prognostic categories for lymph node status, Ki67-entropy, mean of CD8+ cell density in the IZ tumor aspect, and ID of CD8+ cell density. This evidence concerns the gene ESR1 and breast cancer.